Teva Rises On Bullish Five-Year Outlook
Shares of Teva Pharmaceutical Industries pushed higher midday Friday, a day after the world's largest generic drug firm announced a goal of doubling its revenue and increasing its profit margin over the next five years. The Israeli company said its goal is to increase annual revenue to $31 billion and its adjusted profit to $6.8 billion, or 22% of revenue, by 2015. Teva (TEVA), which reports fourth-quarter results on Feb. 9, was on track to log
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here